Increased interleukin 33 in patients with neuro-Behcet's disease: correlation with MCP-1 and IP-10 chemokines.
作者信息
Hamzaoui Kamel, Borhani-Haghighi Afshin, Kaabachi Wajih, Hamzaoui Agnes
机构信息
El Manar Tunis University, Faculty of Medicine of Tunis, Department of Basic Sciences, Tunis, Tunisia.
Health Policy Research Center and Department of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran.
出版信息
Cell Mol Immunol. 2014 Nov;11(6):613-6. doi: 10.1038/cmi.2014.31. Epub 2014 Jun 9.
Abstract
摘要
相似文献
1
Increased interleukin 33 in patients with neuro-Behcet's disease: correlation with MCP-1 and IP-10 chemokines.
Cell Mol Immunol. 2014 Nov;11(6):613-6. doi: 10.1038/cmi.2014.31. Epub 2014 Jun 9.
2
Infliximab for reversible dementia in acute onset of neuro-Behçet's disease: A case report and cytokine analysis.
J Neuroimmunol. 2021 Aug 15;357:577631. doi: 10.1016/j.jneuroim.2021.577631. Epub 2021 Jun 8.
3
CSF levels of cytokines in neuro-Behçet's disease.
Clin Neurol Neurosurg. 2009 Jul;111(6):507-10. doi: 10.1016/j.clineuro.2009.02.001. Epub 2009 Mar 19.
4
Successful treatment of long-standing neuro-Behçet's disease with infliximab.
J Rheumatol. 2005 Jan;32(1):181-3.
5
Significance of CSF immunoglobulins in monitoring neurologic disease activity in Behçet's disease.
Neurology. 1991 Sep;41(9):1398-401. doi: 10.1212/wnl.41.9.1398.
6
Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome.
Clin Immunol Immunopathol. 1997 Jan;82(1):12-7. doi: 10.1006/clin.1996.4268.
7
Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases.
J Neuroimmunol. 2003 Dec;145(1-2):127-34. doi: 10.1016/j.jneuroim.2003.08.040.
8
Association of cerebrospinal fluid IgM index with central nervous system involvement in Behçet's disease.
Arthritis Rheum. 1986 Jun;29(6):793-6. doi: 10.1002/art.1780290614.
9
IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
Lupus. 2016 Aug;25(9):997-1003. doi: 10.1177/0961203316629556. Epub 2016 Feb 3.
10
Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional cerebrospinal fluid neuroinflammatory biomarkers.
PLoS One. 2019 Jul 29;14(7):e0219987. doi: 10.1371/journal.pone.0219987. eCollection 2019.
引用本文的文献
1
Neuro-Behçet's disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis.
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae123.
2
Can early-onset acquired demyelinating syndrome (ADS) hide pediatric Behcet's disease? A case report.
Front Pediatr. 2023 Jun 23;11:1175584. doi: 10.3389/fped.2023.1175584. eCollection 2023.
3
Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.
J Clin Med. 2022 Jul 29;11(15):4415. doi: 10.3390/jcm11154415.
4
The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
Cell Mol Biol Lett. 2022 Feb 2;27(1):10. doi: 10.1186/s11658-022-00311-1.
5
Therapeutic Opportunities of Interleukin-33 in the Central Nervous System.
Front Immunol. 2021 May 17;12:654626. doi: 10.3389/fimmu.2021.654626. eCollection 2021.
6
Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?
Lancet Rheumatol. 2020 Dec;2(12):e779-e790. doi: 10.1016/S2665-9913(20)30340-4. Epub 2020 Oct 9.
7
Serum IL-4, IL-12, IL-13, IL-27, and IL-33 levels in active and inactive ocular Behcet's disease.
Int Ophthalmol. 2020 Dec;40(12):3441-3451. doi: 10.1007/s10792-020-01530-1. Epub 2020 Jul 29.
8
IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases.
Int J Mol Sci. 2019 Nov 22;20(23):5856. doi: 10.3390/ijms20235856.
9
Expression and Function of IL-33/ST2 Axis in the Central Nervous System Under Normal and Diseased Conditions.
Front Immunol. 2018 Nov 20;9:2596. doi: 10.3389/fimmu.2018.02596. eCollection 2018.
10
CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet's disease.
Sci Rep. 2017 Nov 7;7(1):14720. doi: 10.1038/s41598-017-15189-9.
本文引用的文献
1
Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):6-14. Epub 2013 Mar 4.
2
Magnetic resonance imaging findings and outcome of neuro-Behçet's disease: the predictive factors.
Int J Rheum Dis. 2012 Dec;15(6):e142-9. doi: 10.1111/1756-185X.12013. Epub 2012 Oct 27.
3
The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription.
J Immunol. 2011 Aug 15;187(4):1609-16. doi: 10.4049/jimmunol.1003080. Epub 2011 Jul 6.
4
Disease-associated functions of IL-33: the new kid in the IL-1 family.
Nat Rev Immunol. 2010 Feb;10(2):103-10. doi: 10.1038/nri2692. Epub 2010 Jan 18.
5
Treatment of neuro-Behçet's disease: an update.
Expert Rev Neurother. 2009 Apr;9(4):565-74. doi: 10.1586/ern.09.11.
6
Induction of IL-33 expression and activity in central nervous system glia.
J Leukoc Biol. 2008 Sep;84(3):631-43. doi: 10.1189/jlb.1207830. Epub 2008 Jun 13.
7
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
Immunity. 2005 Nov;23(5):479-90. doi: 10.1016/j.immuni.2005.09.015.
8
Chemokines in acute respiratory distress syndrome.
Am J Physiol Lung Cell Mol Physiol. 2005 Jan;288(1):L3-15. doi: 10.1152/ajplung.00405.2003.
9
Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases.
J Neuroimmunol. 2003 Dec;145(1-2):127-34. doi: 10.1016/j.jneuroim.2003.08.040.
10
Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.
Lancet. 1990 May 5;335(8697):1078-80.
Zotero 插件